(Q39859710)

15 September 2017

1 reference

title

Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy (English)

1 reference

15 September 2017

1 reference

2

R N Brogden

1 reference

15 September 2017

R M Pinder

1

1 reference

15 September 2017

T M Speight

series ordinal

3

1 reference

15 September 2017

G S Avery

series ordinal

4

1 reference

15 September 2017

1 February 1977

1 reference

15 September 2017

1 reference

15 September 2017

13

1 reference

15 September 2017

81-123

1 reference

15 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-197713020-00001

15 September 2017

0 references

cites work

Sodium valproate and thrombocytopenia

1 reference

12 December 2020

Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures

1 reference

12 December 2020

The effects of n-dipropylacetate on the acquisition of conditioned behaviour with negative reinforcement in mice

1 reference

12 December 2020

Controlled trial of sodium valproate in severe epilepsy

1 reference

12 December 2020

Sodium valproate in the treatment of resistant epilepsy.

1 reference

12 December 2020

Effects of n-dipropylacetic acid (Depakine) on the activity of the cortical epileptic focus produced with cobalt

1 reference

12 December 2020

Results obtained with Depakine in epilepsy resistant to other therapies. Preliminary note

1 reference

12 December 2020

The treatment of childhood epilepsy with sodium valproate

1 reference

12 December 2020

[Preliminary clinical electroencephalographic study on the treatment of epilepsy with sodium dipropylacetate (Depakine)]

1 reference

12 December 2020

Pharmacodynamic properties of N-dipropylacetic acid

1 reference

12 December 2020

Pharmacokinetics of di-n-propylacetate in epileptic patients

1 reference

12 December 2020

A double blind study of the influence of dipropylacetate on behaviour

1 reference

12 December 2020

Epilepsy and γ-Aminobutyric Acid-Mediated Inhibition

1 reference

12 December 2020

Determination of lower fatty acids, particularly the anti-epileptic dipropyl-acetic acid, in biological materials by means of micro diffusion and gas chromatography

1 reference

12 December 2020

Preliminary notes on the clinical use of sodium diproplyacetate (Depakine) in infantile epilepsy

1 reference

12 December 2020

Huntington's disease: Treatment with dipropylacetic acid and gamma-aminobutyric acid

1 reference

12 December 2020

Effect of sodium valproate on tardive dyskinesia

1 reference

12 December 2020

Experiences on the use of dipropylacetate in the treatment of childhood epilepsy

1 reference

12 December 2020

Clinical trials of anti-epileptic drugs

1 reference

12 December 2020

Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)

1 reference

12 December 2020

The experimental approach to alcoholism

1 reference

12 December 2020

Effect of sodium n-dipropylacetate on audiogenic seizures and brain -aminobutyric acid level.

1 reference

12 December 2020

Letter: Treatment of status epilepticus with sodium valproate.

1 reference

12 December 2020

Sodium salt of n-dipropylacetic acid or Depakin in the therapy of epilepsy. Preliminary note

1 reference

12 December 2020

The use of sodium valproate in a case of status epilepticus

1 reference

12 December 2020

Laboratory evaluation of antiepileptic drugs. Review of laboratory methods

1 reference

12 December 2020

Influence of dipropylacetic acid on hemostasis

1 reference

12 December 2020

Regional distribution in brain and effect on cerebral mitochondrial respiration of the anticonvulsive drug n-dipropylacetate

1 reference

12 December 2020

First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine

1 reference

12 December 2020

[Treatment of refractory epilepsy with dipropyl acetate]

1 reference

12 December 2020

Anticonvulsive therapy using dipropylacetate in children

1 reference

12 December 2020

Modifications by n-dipropylacetic acid (DPA) sodium salt of the activity of alumina induced cortico-motor epileptogenic foci

1 reference

12 December 2020

Absorption and distribution of antiepileptic drugs

1 reference

12 December 2020

Treatment of epilepsy in children using dipropyl acetic acid (DPA)

1 reference

12 December 2020

Results obtained with DPA at the Hôpital de Jour for epileptic patients in Créteil

1 reference

12 December 2020

Treatment of atypical absences with a combination of succinimide and dipropylacetate (author's transl)

1 reference

12 December 2020

Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA.

1 reference

12 December 2020

Dipropylacetate (Dépakine, Ergenyl) in the treatment of epilepsy

1 reference

12 December 2020

Experimental and clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine. Second study

1 reference

12 December 2020

Letter: Sodium valproate in the treatment of intractable childhood epilepsy

1 reference

12 December 2020

[Experiences with dipropylacetate in the treatment of therapy-resistent adult epileptics]

1 reference

12 December 2020

The Toul-ar-C'Hoat experiment: depakine in the treatment of epileptic children. Longitudinal studies of 74 children

1 reference

12 December 2020

PHARMACODYNAMIC PROPERTIES OF 2,2-DIPROPYLACETIC ACID. 2D REPORT ON ITS ANTI-EPILEPTIC PROPERTIES

1 reference

12 December 2020

A clinical note on a new antiepileptic 'Depakine'

1 reference

12 December 2020

Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism.

1 reference

12 December 2020

The inhibitory effect of sodium n-dipropyl acetate on the degradative enzymes of the GABA shunt

1 reference

12 December 2020

Pharmacokinetic study of sodium di-n-propylacetate (usual tablet and enteric coated tablet with delayed absorption) (author's transl)

1 reference

12 December 2020

Hepatoprotective and hepatoregenerative effects of di-n-propylacetic molecules

1 reference

12 December 2020

Sodium valproate in chorea.

1 reference

12 December 2020

Di-n-propylacetic acid--profile of anticonvulsant activity in mice

1 reference

12 December 2020

[Rapid method of quantitative analysis of sodium dipropylacetate in serum or plasma]

1 reference

12 December 2020

Clinical evaluation of sodium dipropylacetate (DPA), a new anti-epileptic drug

1 reference

12 December 2020

Di-N-propylacetic acid in the epileptic syndrome

1 reference

12 December 2020

Anti-epileptic action of the sodium salt of N-dipropylacetic acid. Experimental study in the cat

1 reference

12 December 2020

Prevention of febrile convulsions with dipropylacetate (Depakine)

1 reference

12 December 2020

Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review

1 reference

12 December 2020

Concentration of Dipropylacetate in Plasma

1 reference

12 December 2020

[Action of dipropylacetic acid upon photosensitive Papio papio]

1 reference

12 December 2020

Mechanisms of dyskinesia induction by 1-(3,4-dihydroxyphenyl) piperazine in the rat

1 reference

12 December 2020

Dipropylacetic acid (Depakine) in experimental epilepsy in the alert cat

1 reference

12 December 2020

Electroencephalographic changes in epileptic child treated by Depakene

1 reference

12 December 2020

Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate

1 reference

12 December 2020

[Effect of sodium dipropylacetate on certain varieties of epileptogenic encephalopathies in infants]

1 reference

12 December 2020

Actions and Interactions of Dipropylacetate and Penicillin on Evoked Potentials of Excised Prepiriform Cortex of Guinea Pig

1 reference

12 December 2020

Clinical and electroencephalographical classification of epileptic seizures

1 reference

12 December 2020

Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug

1 reference

12 December 2020

[Studies on a new anticonvulsant drug, sodium dipropylacetate. Assay for metabolites and metabolic pathway]

1 reference

12 December 2020

Metabolism of branched medium chain length fatty acid. I. Omega-oxidation of sodium dipropylacetate in rats

1 reference

12 December 2020

[Blood coagulation changes through dipropyl-acetic-acid (Ergenyl)]

1 reference

12 December 2020

Sodium valproate and platelet function

1 reference

12 December 2020

Sodium valproate in treatment of epilepsy

1 reference

12 December 2020

Clinical observations on the effect of dipropylacetic acid in epileptic and behavioral manifestations

1 reference

12 December 2020

Sodium Valproate in the Treatment of Intractable Childhood Epilepsy

1 reference

12 December 2020

[Depakine (sodium dipropylacetate) in the treatment of epilepsies resistant to other drugs (EEG clinical study in 35 cases followed up for 3-12 months)]

1 reference

12 December 2020

[Clinical experiences with a new antiepileptic agent: dipropyl-acetic acid]

1 reference

12 December 2020

Changes in hemostasis during epilespy treatment using dipropyl acetate. Extended study

1 reference

12 December 2020

Depakine in the treatment of essential or idiopathic epilepsy

1 reference

12 December 2020

Salivary concentrations of antiepileptic drugs

1 reference

12 December 2020

10.2165/00003495-197713020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

15 September 2017

0 references

1 reference